Ionis Pharmaceuticals, Inc. Other Non-Current Liabilities
Ionis Pharmaceuticals, Inc. (IONS) had Other Non-Current Liabilities of $28.43 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-29
- 2026-06-30: Other Liabilities, Noncurrent $28.43M.
- 2026-03-31: Other Liabilities, Noncurrent $28.27M.
- 2025-12-31: Other Liabilities, Noncurrent $28.12M.
- 2025-09-30: Other Liabilities, Noncurrent $28.79M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $28.43M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $28.27M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $28.12M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $28.79M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $59.07M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $55.67M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $51.92M 10-Q · filed 2025-10-29 | |
| 2024-09-30 | $41.73M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $41.77M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $41.80M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $41.84M 10-Q · filed 2024-11-06 | |
| 2023-09-30 | $48.80M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $16.44M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.49M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $15.97M 10-Q · filed 2023-11-02 | $7.13M 10-K · filed 2023-02-22 |
| 2021-12-31 | $6.95M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |